#United States #share buyback #dividend increase #Quest Diagnostics #Secaucus

Quest Diagnostics Celebrates 15 Years of Dividend Increases

Quest Diagnostics Incorporated, a premier provider of diagnostic information services, has recently revealed significant financial advancements, exciting both shareholders and the broader investment community. The company's Board of Directors approved a 7.5% increase in its quarterly cash dividend, raising it from $0.80 to $0.86 per share. This adjustment will take effect on April 20, 2026, for shareholders recorded as of April 6, 2026, and translates into an annual dividend of $3.44 per share.

This is not just a routine dividend increase; it is a remarkable achievement, marking the 15th consecutive year that Quest Diagnostics has raised its dividend. This consistent growth highlights the company’s commitment to delivering value to its shareholders and reflects a strong financial performance that underpins these dividends.

In addition to the dividend increase, the Board of Directors has also sanctioned a $1 billion increase in its share repurchase authorization. This is an extension of the nearly $0.4 billion that was already in place as of December 31, 2025. The expansion of the share repurchase program indicates management's confidence in the company's future prospects and their proactive approach to enhancing shareholder value.

About Quest Diagnostics

Quest Diagnostics is dedicated to improving health and wellness across the nation. The organization connects healthcare professionals and consumers with critical diagnostic insights that not only facilitate better health outcomes but also promote preventative care strategies. With nearly 57,000 employees, Quest serves approximately half of the physicians and hospitals in the United States, reaching about one in three American adults each year.

The company’s enduring commitment to smarter and simpler testing allows it to pave the way for innovative strategies that lead to disease identification and management, healthier behaviors, and improved oversight of health conditions. The impressive growth of dividend payments and share repurchases reflects the strength of Quest Diagnostics in providing critical information and fostering significant advancements in health management.

In a time where investors look for companies that prioritize both stability and growth, Quest Diagnostics continues to set a precedent in shareholder engagement and market confidence. As healthcare evolves, so too does Quest Diagnostics, adapting to the challenges and opportunities that lie ahead, ensuring they remain at the forefront of diagnostic services. The latest shareholder announcements not only underscore their financial health but also aim to enhance the transparency and accessibility of healthcare for communities nationwide.

For further details, investors and interested parties can visit Quest Diagnostics Official Website.